TP53 and neoplasm: In our exploration of the suppressive effects of the PRIMA‐1met–L‐OHP combination on malignant transformation, the activity of the single drug or the combination was analyzed in in vitro tumor formation assays with HCT116 (p53‐wt) and DLD‐1 (p53‐mutant) cells growing in soft agar.